Regenerative Cardiovascular Therapies: Stem Cells and Beyond

Bernhard Wernly(Paracelsus Medical University), Michael Lichtenauer(Medical University of Vienna), Attila Kiss(Karolinska Institutet), Christian Jung(Heinrich Heine University Düsseldorf), Christine Prodinger(University of Salzburg), Uta C. Hoppe(Baker Heart and Diabetes Institute), Richard Rezar(University of Salzburg), Bruno K. Podesser(Ludwig Boltzmann Institute for Cardiovascular Research), Moritz Mirna(Paracelsus Medical University)
International Journal of Molecular Sciences
March 21, 2019
10.3390/ijms20061420
Cited by 59

Related Papers

Effect of Renal Sympathetic Denervation on Glucose Metabolism in Patients With Resistant Hypertension
|Circulation|2011|569
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study
|The Lancet|2022|310
Virtual and augmented reality in critical care medicine: the patient’s, clinician’s, and researcher’s perspective
|Critical Care|2022|229
The Sequential Organ Failure Assessment (SOFA) Score: has the time come for an update?
|Critical Care|2023|204
The impact of frailty on survival in elderly intensive care patients with COVID-19: the COVIP study
|Critical Care|2021|188